Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (7147)	9/3/1998 9:26:00 AM
From: Robert K.	Respond to of 17367

Eurpoe has been fairly immune to asia. No longer. This will put great pressure on the Dow. Japan is still the market killer, and still holds over 14,000. I am not letting this alter my x position.

To: Robert K. who wrote (7147)	9/3/1998 9:39:00 AM
From: aknahow	Read Replies (2) \| Respond to of 17367

XOMA does not have anyone on the DSMB. Fact not opinion! Slugger is right that the total death data provides a hint as to what is going on. I wish they had not kept this information from us supposedly at the request of the DSMB. Agree that the data might mean less than one thinks due to standards of care etc. The best information would come from health care workers involved in the trials but they too could be mistaken in their feelings on who was getting Neuprex.